Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
Tortajada-Girbés M, Bousquet R, Bosque M, Carrera Martínez JJ, Ibáñez MD, Moreira A, Nieto A, Plaza AM, Rivas C, Requena G, Sánchez-Solis M, Tabar A, Torres-Borrego J, Zapatero L. Tortajada-Girbés M, et al. Among authors: bosque m. Expert Rev Respir Med. 2018 Sep;12(9):745-754. doi: 10.1080/17476348.2018.1507740. Epub 2018 Aug 28. Expert Rev Respir Med. 2018. PMID: 30141696 Review.
[Immunotherapy with acarus extract in children under the age of 5 years].
Paniagua MJ, Bosque M, Asensio O, Larramona H, Marco MT. Paniagua MJ, et al. Among authors: bosque m. Allergol Immunopathol (Madr). 2002 Jan-Feb;30(1):20-4. doi: 10.1016/s0301-0546(02)79082-4. Allergol Immunopathol (Madr). 2002. PMID: 11888488 Clinical Trial. Spanish.
[Allergic rhinitis and bronchial hyperreactivity].
Valdesoiro L, Bosque M, Marco MT, Asensio O, Antón J, Larramona H. Valdesoiro L, et al. Among authors: bosque m. Allergol Immunopathol (Madr). 2004 Nov-Dec;32(6):340-3. doi: 10.1016/s0301-0546(04)79266-6. Allergol Immunopathol (Madr). 2004. PMID: 15617661 Review. Spanish.
A prospective and multicenter safety-monitoring study of a short up-dosing schedule of immunotherapy with a mass-units-standardized extract of mites.
Gamboa P, González G, Jauregui I, Jorró G, Molero I, Eseverri JL, González R, Luna I, Marcos C, Miró J, Pulido Z, Gracia T, Iriarte P, Carreño A, Navarro JA, Rocafort S, García-Robaina JC, Souto I, Casas R, Lleonart R, Nevot S, Asensio O, Bosque M, Blasco A, de la Torre F. Gamboa P, et al. Among authors: bosque m. Allergol Immunopathol (Madr). 2004 Jan-Feb;32(1):13-7. doi: 10.1016/s0301-0546(04)79217-4. Allergol Immunopathol (Madr). 2004. PMID: 14980190
[Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
Almagro E, Asensio O, Bartolomé JM, Bosque M, de la Hoz B, Dolz I, Elorza J, Ferreiro M, García JM, Losada E, et al. Almagro E, et al. Among authors: bosque m. Allergol Immunopathol (Madr). 1995 Jul-Aug;23(4):153-9. Allergol Immunopathol (Madr). 1995. PMID: 8553989 Clinical Trial. Spanish.
[Chronic bronchopneumopathies. Round table].
Martínez Valverde A, Argemi Renom J, Bosque M, Marco MT, Pérez Frías J, Martínez Antón J, Pérez Navero JL, Romanos Lezcano A, Moya M, Juste M, et al. Martínez Valverde A, et al. Among authors: bosque m. An Esp Pediatr. 1987 Nov;27 Suppl 29:15-26. An Esp Pediatr. 1987. PMID: 3442354 Spanish. No abstract available.
77 results